VeriMomDois-je éviter methyl estradiolpropanoate pendant la grossesse ? | VeriMom
Topical Methyl Estradiolpropanoate (MEP) has been shown in human studies to activate estrogenic effects in skin (clinical trials of Emepelle products), indicating estrogen receptor activity and potential for systemic exposure; estradiol and active estrogens have known reproductive/teratogenic risks in pregnancy, so this derivative is a suspected reproductive hazard. Sources: clinical studies showing topical efficacy and product ingredient lists. (PubMed clinical trial; product ingredient pages).
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- methyl estradiolpropanoate est-il sûr pendant la grossesse ?
- Topical Methyl Estradiolpropanoate (MEP) has been shown in human studies to activate estrogenic effects in skin (clinical trials of Emepelle products), indicating estrogen receptor activity and potential for systemic exposure; estradiol and active estrogens have known reproductive/teratogenic risks in pregnancy, so this derivative is a suspected reproductive hazard. Sources: clinical studies showing topical efficacy and product ingredient lists. (PubMed clinical trial; product ingredient pages).
- methyl estradiolpropanoate est-il sûr pendant l'allaitement ?
- Because MEP is an estrogen derivative with demonstrated topical activity, it is reasonably suspected to produce systemic estrogenic exposure after dermal application; estradiol transfers into breast milk, so a conservative classification is 'suspected' hazard for breastfeeding unless data showing negligible systemic absorption are provided. No regulatory harmonised CMR classification or EU ban/restriction was found to override this assessment.
- methyl estradiolpropanoate est-il sûr pour la peau de bébé ?
- Hazard and mechanism mirror adults (suspected estrogenic reproductive hazard / demonstrated estrogen receptor activity). Exposure score is increased for infant skin because infant skin has higher absorption (immature barrier, higher surface‑area‑to‑weight) and the ingredient has measurable topical activity in adults, so exposure to a baby (0–3 yr) would be higher.
- Comment VeriMom évalue-t-il methyl estradiolpropanoate ?
- VeriMom évalue methyl estradiolpropanoate à 33/100 (risque élevé) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à methyl estradiolpropanoate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à methyl estradiolpropanoate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.